Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2011
11/03/2011US20110269946 Protein separation device
11/03/2011US20110269797 Anln protein as an endocrine treatment predictive factor
11/03/2011US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
11/03/2011US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011US20110269670 Carbohydrate binding molecules
11/03/2011US20110269649 Active nems arrays for biochemical analyses
11/03/2011US20110269643 Mass spectrometric methods for detecting mutations in a target nucleic acid
11/03/2011US20110269642 Modular assay plates, reader systems and methods for test measurements
11/03/2011US20110269636 Materials and methods for identifying patients at heighten risk for developing her2+ related brain tumors
11/03/2011US20110269634 Methods and Compositions for Risk Stratification
11/03/2011US20110269249 Distribution of particles in chamber by application of magnetic field
11/03/2011US20110269248 Bio-markers for diagnosing diabetic retinopathy
11/03/2011US20110269247 Measurement kit and an immunochromatography method
11/03/2011US20110269246 Measuring levels of frataxin
11/03/2011US20110269245 Methods and kits for detection of toxemia
11/03/2011US20110269244 Ligand-directed covalent modification of protein
11/03/2011US20110269240 Immobilizing chemical or biological sensing molecules on semi-conducting nanowires
11/03/2011US20110269237 Catalytically-generated gas in hydrocarbon bearing source rocks
11/03/2011US20110269227 Peptide having bindability with adiponectin, analysis method utilizing same peptide, and analysis device utilizing same peptide
11/03/2011US20110269175 Methods for sorting particles
11/03/2011US20110269159 Reagents for reducing leukocyte interference in immunoassays
11/03/2011US20110269158 Use of s-erbb-3 as a marker for cancer
11/03/2011US20110269157 Immunological Test For Detecting Autoantibodies Against Testicular Antigens
11/03/2011US20110269155 Detecting Antigen Responsive Cells in a Sample
11/03/2011US20110269154 Methods for Diagnosis, Prognosis and Methods of Treatment
11/03/2011US20110269153 Immunoassay Device with Improved Sample Closure
11/03/2011US20110269152 Anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by the CHO cell
11/03/2011US20110269151 Centrifugal micro-fluidic device and method for immunoassay
11/03/2011US20110269150 Compositions and methods for predicting cardiovascular events
11/03/2011US20110269149 Method for quantification of body internal concentration of protein-based drug
11/03/2011US20110269146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
11/03/2011US20110269144 Ryanodine receptor polypeptides
11/03/2011US20110269142 Clinical Method for Individualized Epithelial Cancer Screening Involving ERCC5 and IGF2R Genetic Testing and Gene-Environment Interactions
11/03/2011US20110269141 Target protein and target gene for drug discovery, and screening method
11/03/2011US20110269139 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
11/03/2011US20110269133 Compositions and Methods For Detecting The Presence Of Cryptosporidium Parvum In A Test Sample
11/03/2011US20110269131 Substrate for manufacturing disposable microfluidic devices
11/03/2011US20110269124 Methods, Primers, Probes and Kits Useful for the Detection of BRAF Mutations
11/03/2011US20110269123 Marker for gastric cancer and method for detecting gastric cancer
11/03/2011US20110269115 Heated Assays for Influenza
11/03/2011US20110268818 Ngal-binding siderophores and use thereof to treat iron deficiency and iron overload
11/03/2011US20110268795 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes mellitus, prediabetic symptoms, insulin resistance and related disease states and conditions
11/03/2011US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions
11/03/2011US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011US20110268744 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
11/03/2011US20110268742 Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
11/03/2011US20110268739 Human binding molecules having killing activity against enterococci and uses thereof
11/03/2011US20110268738 Antibodies Against Hmgb1 and Fragments Thereof
11/03/2011US20110268727 Anti-interferon-alpha antibodies
11/03/2011US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011US20110268673 Skin Treatment
11/03/2011US20110268661 Fluorescent fusion polypeptides and methods of use
11/03/2011US20110268612 Microchannel into which a porous polymer is inserted
11/03/2011US20110268611 Liquid-mixing apparatus, chemical testing apparatus, and endoscope processing apparatus
11/03/2011US20110267618 Passive reflective tracking media compositions and methods for covertly tracking objects
11/03/2011US20110267457 Systems and methods for nucleic acid sequencing
11/03/2011US20110267080 Remote Oil Monitoring System
11/03/2011US20110267028 Measuring device and methods for use therewith
11/03/2011US20110266953 Solar powered light assembly to produce light of varying colors
11/03/2011US20110266150 Biosensor Strip
11/03/2011US20110266149 Electrochemical sensor module
11/03/2011US20110265555 Method and apparatus for vapor signature with heat differential
11/03/2011US20110265554 Method and apparatus for vapor signature with heat differential
11/03/2011US20110265553 Method and apparatus for determining a vapor signature based upon frequency
11/03/2011US20110265552 System and method for quantifying the presence of components in the exhaust of commercial and/or heavy-duty vehicles
11/03/2011US20110265548 Underfill Detection System For A Biosensor
11/03/2011DE102010019178A1 Vorrichtung und Verfahren zur Prüfung der Luftdurchlässigkeit von Textilien Apparatus and method for testing the air permeability of textiles
11/03/2011DE102010018736A1 Thyroidhormonrezeptorexpression zur Diagnose und Prognose von Brustkrebs und Eierstockkrebs Thyroidhormonrezeptorexpression for the diagnosis and prognosis of breast cancer and ovarian cancer
11/03/2011DE102010018561A1 Quantitative Marker zur Bestimmung des mentalen Status eines Probanden Quantitative marker for the determination of mental status of a subject
11/03/2011CA2797429A1 Semipermanently closed microfluidic valve
11/03/2011CA2795549A1 Methods for detecting antibodies
11/02/2011EP2383580A1 "Real time binding analysis of antigens on a biosensor surface"
11/02/2011EP2383579A1 sFlt-1, cardiac troponins and natriuretic peptides in the recognition of therapy with HER-2 inhibitors
11/02/2011EP2383578A1 Tumor marker and methods of use thereof
11/02/2011EP2383577A1 Diagnostic method for predicting the response of a patient to chemovirotherapy or radiovirotherapy
11/02/2011EP2383576A1 Micro-electrode grid array for top and bottom recording from samples
11/02/2011EP2383575A1 Method for pretreating specimen and method for assaying biological substance
11/02/2011EP2383574A2 Sequential analysis of biological samples
11/02/2011EP2383573A1 Screening method for substance useful as agent for treating prostate cancer
11/02/2011EP2383572A1 Cellular humoral activation test (CHAT)
11/02/2011EP2383571A1 Growth differntioation factor 15 (GDF 15) for risk prediction of diabetic foot ulcer
11/02/2011EP2383570A2 Measuring device, measuring method, and program
11/02/2011EP2383569A1 Image analysis apparatus, image analysis method, image analysis program and recording medium
11/02/2011EP2383568A1 Method and device for testing the air permeability of textiles
11/02/2011EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011EP2383296A1 Antibody for the thyrotropin receptor and uses thereof
11/02/2011EP2383294A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
11/02/2011EP2383293A1 Immunoassay for Chromogranin A, antibodies and kit
11/02/2011EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011EP2383288A2 Differential in tumour gene products and use of same
11/02/2011EP2383287A1 Citrobacter rodentium secreted proteins
11/02/2011EP2383280A1 Expression system for toxic ion channels, in particular ryanodine receptors
11/02/2011EP2383278A1 Method to determine B cell mediated diseases
11/02/2011EP2382475A2 Biomarkers for appetite regulation
11/02/2011EP2382474A1 Soluble icam-1 as biomarker for prediction of therapeutic response
11/02/2011EP2382473A1 Tumor markers and methods of use thereof
11/02/2011EP2382472A1 Methods and compositions for diagnostic use in cancer patients
11/02/2011EP2382471A1 Microarrays for allergen-specific ige